Cancer clinical trials in the region Pays de la Loire

236 currently recruiting clinical trials
Region Pays de la Loire

Phase 2 Lymphoma #NCT06558604 #2023-506706-40-00
B cell lymphoma Mantel cell lymphoma Early (stage I and II) Disseminated (stage III and IV) None > 60 ml/min 50-60 ml/min 30-50 ml/min 1 2 3 or more Targeted therapy
Bispecific T-cell engager antibodies
Centre Hospitalier Universitaire de Nantes (Nantes)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2 Pancreas cancer #NCT06757244 #2023-510004-49-00
Adenocarcinoma Metastatic None Systemic Treatment-Naive Systemic Treatment-Naive
Centre Hospitalier Universitaire de Nantes (Nantes)
Hopital Foch
Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT06660654 #2024-513307-13-00
Invasive bladder cancer Upper excretory tract cancer Urethral cancer Locally Advanced Metastatic 1 2 3 or more Immunotherapy
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Daiichi Sankyo
Phase 2 Lymphoma #NCT04802590 #2024-512634-15-00
B cell lymphoma Mantel cell lymphoma None CD20 > 60 ml/min 50-60 ml/min None Systemic Treatment-Naive
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2 Endometrial cancer #NCT06660654 #2024-513307-13-00
Locally Advanced Metastatic 1 2 3 or more Immunotherapy Chemotherapy
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Daiichi Sankyo
Phase 2 Lung cancer #NCT05732831 #2022-502645-99-00
SCLC (Small Cell Lung Cancer) NSCLC (Non-Small Cell Lung Cancer) Mesothelium Locally Advanced Metastatic MTAP 1 2 3 or more
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Tango Therapeutics
Phase 2 Breast cancer #NCT05955170 #2022-500743-20-00
HER2 Positive Metastatic 1 Chemotherapy Targeted therapy Chemotherapy Targeted therapy
Hôpital Privé du Confluent - Vivalto Santé (Nantes)
Institut Curie
Phase 2 Lung cancer #NCT05498428 #2023-505065-91-00
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic 1 Bispecific T-cell engager antibodies
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Janssen
Phase 2 Lymphoma #NCT05963074 #2023-504044-34-00
B cell lymphoma Lymphocytic lymphoma None None Systemic Treatment-Naive
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes)
Janssen
Phase 2 Pancreas cancer #NCT06172478 #2023-507641-29-00
Adenocarcinoma Locally Advanced Metastatic 1
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Nantes (Nantes)
Daiichi Sankyo